WaveMan · Form 4
Hyep Ivan insider trades
> Search tickers & screens ⌘K
LIVE

Hyep Ivan insider trades

Hyep Ivan has filed 12 Form 4s with the SEC that we hold, all for Bicara Therapeutics Inc. (BCAX), as Chief Financial Officer. Across all of them we count 0 purchases worth $0 and 17 sales worth $3.2M reported on Form 4. In the last 12 months: 0 purchases ($0) and 13 sales ($2.6M). The largest single trade was a sale of 22,757 shares of Bicara Therapeutics Inc. worth $650.9K, dated 2026-07-08. The first filing on our record is dated 2025-10-08 and the latest 2026-08-12.

Bicara Therapeutics Inc. (BCAX)

Chief Financial Officer · 12 filings · 17 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-10-06S, sale reported on Form 46,514$118.4K2025-10-08
2025-10-07S, sale reported on Form 418,244$332.4K2025-10-08
2025-10-08S, sale reported on Form 45,627$102.5K2025-10-08
2025-10-09S, sale reported on Form 46,415$116.9K2025-10-10
2025-11-21S, sale reported on Form 4605$11.0K2025-11-25
2025-11-24S, sale reported on Form 417,795$330.1K2025-11-25
2025-12-22S, sale reported on Form 49,200$168.5K2025-12-23
2026-01-22S, sale reported on Form 41,882$34.2K2026-01-26
2026-03-03S, sale reported on Form 413,555$247.0K2026-03-05
2026-03-04S, sale reported on Form 42,963$54.1K2026-03-05
2026-03-23S, sale reported on Form 49,200$170.4K2026-03-24
2026-04-21S, sale reported on Form 49,200$211.6K2026-04-22
2026-05-21S, sale reported on Form 49,200$187.9K2026-05-26
2026-07-08S, sale reported on Form 422,757$650.9K2026-07-10
2026-07-08S, sale reported on Form 44,413$131.6K2026-07-10
2026-07-08S, sale reported on Form 4830$25.2K2026-07-10
2026-08-10S, sale reported on Form 412,500$349.6K2026-08-12
Source

Counted from the Form 4 filings this reporting owner (SEC CIK 2034668) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms